Projects per year
Fingerprint
Dive into the research topics where Sana Arnouk is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
FWOSB79: A novel cancer therapy that selectively targets tumor-infiltrating regulatory T cells
Van Ginderachter, J., Laoui, D. & Arnouk, S.
1/11/19 → 31/10/21
Project: Fundamental
Research output
-
IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D
Kiss, M., Vande Walle, L., Saavedra, P. H. V., Lebegge, E., Van Damme, H., Murgaski, A., Qian, J., Ehling, M., Pretto, S., Bolli, E., Keirsse, J., Bardet, P. M. R., Arnouk, S. M., Elkrim, Y., Schmoetten, M., Brughmans, J., Debraekeleer, A., Fossoul, A., Boon, L., Raes, G. & 8 others, , Mar 2021, In : Cancer Immunology Research. 9, 3, p. 309-323 15 p.Research output: Contribution to journal › Article
1 Citation (Scopus) -
Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked Nanobodies
Bolli, E., Scherger, M., Arnouk, S., Pombo Antunes, A. R., Straßburger, D., Urschbach, M., Stickdorn, J., De Vlaminck, K., Movahedi, K., Räder, H. J., Hernot, S., Besenius, P., Van Ginderachter, J. & Nuhn, L., 8 Mar 2021, In : Advanced Science. 2004574, 12 p.Research output: Contribution to journal › Article
Open Access -
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy: Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy
Lebegge, E., Arnouk, S. M., Bardet, P. M. R., Kiss, M., Raes, G. & Van Ginderachter, J. A., 9 Jul 2020, In : Frontiers in Immunology. 11, 1395, p. 1-14 14 p., 1395.Research output: Contribution to journal › Scientific review
2 Citations (Scopus) -
Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels.
Scherger, M., Bolli, E., Pombo Antunes, A. R., Arnouk, S., Stickdorn, J., Van Driessche, A., Schild, H., Grabbe, S., De Geest, B., Van Ginderachter, J. & Nuhn, L., 1 Oct 2020, In : Cells. 9, 10, 14 p., 2222.Research output: Contribution to journal › Article
3 Citations (Scopus) -
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors
Bolli, E., D'Huyvetter, M., Murgaski, A., Berus, D., Stangé, G., Clappaert, E. J., Arnouk, S., Pombo Antunes, A. R., Krasniqi, A., Lahoutte, T., Gonçalves, A., Vuylsteke, M., Raes, G., Devoogdt, N., Movahedi, K. & Van Ginderachter, J. A., 28 Nov 2019, In : Journal of Controlled Release. 314, p. 1-11 11 p.Research output: Contribution to journal › Article
7 Citations (Scopus)
Thesis
-
Nanobody-based targetting of pro-tumoral tumor-associated marcophages as novel cancer therapy
Author: Arnouk, S. & Ballet, S., 4 Sep 2018Supervisor: Van Ginderachter, J. (Promotor)
Student thesis: Master's Thesis